1 / 84

OTOSCLEROSIS

jamese
Download Presentation

OTOSCLEROSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


    1. ??? ???? ?????? ??????

    2. OTOSCLEROSIS

    3. DEFINITION A primary disease of the otic capsule characterized pathologically by abnormal resorption and deposition of bone

    4. HISTOPATHOLOGY Resorption of bone by osteocytes Formation of new vascular spongy bone Formation of dense sclerotic bone

    5. AREAS OF PREDILECTION Fissula ante fenestram (80% to 90%)

    6. OTHER AREAS Round window, the apex of the cochlea, the cochlear aqueduct, the semicircular canals, and the stapes footplate itself

    7. COCHLEAR INVOLVEMENT

    8. ETIOLOGY Unknown cause Positive family history in about 60% Inherited by autosomal dominant transmission with incomplete penetration (60%) Persistent measles virus infection Detection of measles virus RNA in the affected bone Detection of measles virus-specific antibodies in the perilymph

    9. PHYSIOLOGY Conductive HL: due to fixation of the stapedial footplate Mixed HL: due to Liberation of toxic metabolites into the inner ear Vascular compromise from sclerosis and narrowing of vascular channels Direct extension of lesions into the inner ear Cochlear otosclerosis

    11. CLINICAL PRESENTATION Hearing loss of gradual onset at 15 - 45 years Slowly progressive course 70% are bilateral Accelerates with pregnancy (30-40%) Tinnitus Paracusis Willisii Change of the speech pattern Vestibular symptoms

    12. PHYSICAL EXAMINATION Normal tympanic membrane Schwartze sign (Flamingo flush)

    13. PHYSICAL EXAMINATION Normal tympanic membrane Schwartze sign (Flamingo flush) Tuning fork tests

    14. PURE TONE AUDIO

    15. CARHART’S NOTCH Decrease in bone conduction thresholds 5 dB at 500 Hz 10 dB at 1000 Hz 15 dB at 2000 Hz 5 dB at 4000 Hz Explanation is not known Reverses following successful surgery

    16. AUDIOMETRY Pure tone audiogram Speech discrimination

    17. AUDIOMETRY Pure tone audiogram Speech discrimination Impedence & tympanometry

    18. CT SCAN

    19. COCHLEAR OTOSCLEROSIS Isolated pure sensorineural hearing loss without a conductive component

    20. CRITERIA FOR DIAGNOSIS OF COCHLEAR OTOSCLEROSIS Progressive pure cochlear loss beginning at the usual age of onset for otosclerosis Unilateral conductive hearing loss consistent with otosclerosis and bilateral symmetric SNHL Positive Schwartze’s sign Positive family history Excellent discrimination Stapedial reflex demonstrating the “on-off effect” CT: demineralization of the cochlea

    21. DIFFERENTIAL DIAGNOSIS Congenital fixation of the stapes Middle ear effusion Chronic OM and ossicular discontinuity Tympanosclerosis Malleus head fixation Systemic diseases

    22. SYSTEMIC DISEASES Osteogenesis imperfecta Stapes fixation Blue sclera Fractures

    23. SYSTEMIC DISEASES Osteogenesis imperfecta Stapes fixation Blue sclera Fractures Pagets disease Crowding in epitympanum Elevated alkaline phosphatase Skeletal bone involvement

    24. TREATMENT Observation Hearing aid Medical treatment Surgical treatment

    25. OBSERVATION

    26. INDICATIONS OF OBSERVATION Unilateral Mild CHL Young age

    27. HEARING AID

    28. INDICATIONS OF HEARING AID Refuse surgery Poor surgical candidate Following improvement of CHL

    29. MEDICAL TREATMENT

    30. AIM OF MEDICAL TREATMENT Stabilize the disease by reduction of the osteoclastic bone resorption and increase osteoblastic bone formation

    31. MEDICAL MANAGEMENT Sodium fluoride: 50-75 mg /day/2years followed by 25 mg for life Vitamin D Calcium carbonate

    32. INDICATIONS Cochlear otosclerosis Patients with confirmed otosclerosis but having progressive SNHL disproportionate to age

    33. CONTRAINDICATIONS Chronic nephritis Rheumatoid arthritis Pregnancy and lactation Children

    34. SURGICAL TREATMENT

    35. PATIENT SELECTION FOR SURGICAL TREATMENT Socially unacceptable conductive or mixed hearing loss Good speech discrimination Age Lifestyle and occupation

    36. ABSOLUTE CONTRAINDICATION OF SURGERY The better or the only functioning ear

    37. OTHER CONTRAINDICATIONS ? Patients experience frequent changes in barometric pressure “Malignant” otosclerosis Endolymphatic hydrops TM perforation Infections

    38. STAPES SURGERY

    39. STAPEDECTOMY Results probably are the best More traumatic to the inner ear Increased post-op vestibular symptoms Higher incidence of postoperative SNHL The operation is unavoidable in: Comminuted fracture of the footplate Revision surgery

    40. STAPEDOTOMY Equal or better results with less vestibulocochlear side effects

    41. COMPARISON

    42. STAMP Preservation of the stapedius tendon Reduction in hyperacusis Reduction in risk for long-term postoperative inner ear injuries No prosthesis complications Very difficult technique

    43. SURGICAL PROCEDURE

    44. The Incision

    50. STAPEDOTOMY

    51. LASER STAPEDOTMY

    52. STAMP

    53. OPERATIVE PROBLEMS & COMPLICATIONS

    54. TM PERFORATION Proceed and then repair

    55. CHORDA TYMPANI INJURY 30% of cases Metallic taste Symptoms usually resolves in 3-4 months More symptoms if bilateral

    56. OBTRUSIVE FACIAL NERVE 0.5 % Stapedotomy is usually possible

    58. BLEEDING Mucosal trauma Active phase Persistent stapedial artery

    59. Persistent stapedial artery

    62. ROUND WINDOW OTOSCLEROSIS About 1% complete (Shuknecht) If complete: Abandon surgery If incomplete or not sure: Do not remove bone and proceed

    63. OBLITERATIVE OTOSCLEROSIS OF THE OVAL WINDOW A total stapedectomy is contraindicated because of high risk of surgically induced SNHL

    64. INCUS PROBLEMS Subluxation: Proceed Dislocation: Remove incus & use a malleus-grip prosthesis

    65. FLOATING FOOTPLATE May be avoided if control holes are used or by using laser fenestration

    66. FLOATING FOOTPLATE May be extracted by needles/hooks with hole inferior to the oval window

    67. FLOATING FOOTPLATE In many cases should be left and surgery is completed with unpredictable results or use laser fenestration

    68. MALLEUS ANKYLOSIS About 0.5% May be congenital or acquired Causes about 15-20 dB CHL Remove malleus head and the incus and use malleus grip prosthesis

    69. CSF GUSHER Due to fundal defect of IAM or widened cochlear aqueduct Introduce spinal catheter and proceed Or Pack with fascia and gauze for 4-5 days with delayed reconstruction that avoid reopening the fenestra

    70. PERILYMPH FISTULA Primary or secondary

    71. PREVENTION OF PERILYMPH FISTULA Stapedectomy < stapedotomy Oval window seal No fat or gel-foam for seal Prohibit nose blowing, flying, diving, & lifting heavy objects postoperatively

    72. DIAGNOSIS OF PERILYMPH FISTULA Drop or fluctuation in hearing Vertigo & tinnitus Audiometry ENG Fistula test Radiology

    75. TREATMENT Surgical closure

    76. REPARATIVE GRANULOMA Granuloma formation around the prosthesis and incus 1-5% Gradual deterioration 5-15 days postoperativly Vertigo, tinnitus and deafness Otoscopy: reddish discoloration of the posterior TM

    77. REPARATIVE GRANULOMA Treatment is by emergency tympanotomy and excision

    78. SNHL 0.2-10% Serous labyrinthitis - high frequencies Surgical trauma

    79. PERSISTENCE OR RECURRENCE OF CHL Prosthesis malfunction Fibrous adhesion Incus erosion

    83. PERSISTENCE OR RECURRENCE OF CHL Prosthesis malfunction Fibrous adhesion Incus erosion Missed pathology: e.g. malleus fixation, round window otosclerosis Otosclerosis regrowth

    84. RARE COMPLICATIONS Facial paralysis Acute otitis media Cholesteatoma

    85. THANK YOU

More Related